Goldman Sachs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.18M | Sell |
52,400
-291,100
| -85% | -$17M | ﹤0.01% | 4125 |
|
|
2025
Q4 | $18.5M | Hold |
343,500
| – | – | ﹤0.01% | 2459 |
|
|
2025
Q3 | $15.5M | Sell |
343,500
-147,100
| -30% | -$6.87M | ﹤0.01% | 2515 |
|
|
2025
Q2 | $22.7M | Buy |
490,600
+71,100
| +17% | +$3.49M | ﹤0.01% | 2015 |
|
|
2025
Q1 | $25.6M | Sell |
419,500
-454,500
| -52% | -$26.5M | ﹤0.01% | 1784 |
|
|
2024
Q4 | $49.4M | Buy |
874,000
+509,000
| +139% | +$28.4M | 0.01% | 1301 |
|
|
2024
Q3 | $18.9M | Hold |
365,000
| – | – | ﹤0.01% | 2121 |
|
|
2024
Q2 | $15.2M | Sell |
365,000
-91,200
| -20% | -$4.08M | ﹤0.01% | 2116 |
|
|
2024
Q1 | $24.7M | Buy |
456,200
+82,500
| +22% | +$4.2M | ﹤0.01% | 1659 |
|
|
2023
Q4 | $19.2M | Buy |
373,700
+76,100
| +26% | +$3.99M | ﹤0.01% | 1940 |
|
|
2023
Q3 | $17.3M | Buy |
297,600
+83,300
| +39% | +$5.1M | ﹤0.01% | 1936 |
|
|
2023
Q2 | $13.7M | Buy |
214,300
+108,400
| +102% | +$7.27M | ﹤0.01% | 2168 |
|
|
2023
Q1 | $7.34M | Sell |
105,900
-40,900
| -28% | -$2.88M | ﹤0.01% | 2700 |
|
|
2022
Q4 | $10.6M | Buy |
146,800
+60,100
| +69% | +$4.53M | ﹤0.01% | 2528 |
|
|
2022
Q3 | $6.16M | Sell |
86,700
-143,400
| -62% | -$10.4M | ﹤0.01% | 2951 |
|
|
2022
Q2 | $17.7M | Buy |
230,100
+99,200
| +76% | +$7.56M | ﹤0.01% | 1998 |
|
|
2022
Q1 | $9.56M | Sell |
130,900
-63,700
| -33% | -$4.28M | ﹤0.01% | 2740 |
|
|
2021
Q4 | $12.1M | Buy |
194,600
+25,300
| +15% | +$1.48M | ﹤0.01% | 2585 |
|
|
2021
Q3 | $10M | Sell |
169,300
-927,600
| -85% | -$61.1M | ﹤0.01% | 2721 |
|
|
2021
Q2 | $73.3M | Buy |
1,096,900
+669,200
| +156% | +$43.6M | 0.02% | 962 |
|
|
2021
Q1 | $27M | Buy |
427,700
+74,600
| +21% | +$4.64M | 0.01% | 1678 |
|
|
2020
Q4 | $21.9M | Buy |
353,100
+210,400
| +147% | +$12.9M | 0.01% | 1772 |
|
|
2020
Q3 | $8.6M | Buy |
142,700
+14,500
| +11% | +$873K | ﹤0.01% | 2449 |
|
|
2020
Q2 | $7.54M | Buy |
128,200
+30,200
| +31% | +$1.81M | ﹤0.01% | 2469 |
|
|
2020
Q1 | $5.46M | Sell |
98,000
-1,927,000
| -95% | -$118M | ﹤0.01% | 2565 |
|
|
2019
Q4 | $130M | Buy |
2,025,000
+1,382,500
| +215% | +$79.2M | 0.03% | 575 |
|
|
2019
Q3 | $32.6M | Buy |
642,500
+91,500
| +17% | +$4.3M | 0.01% | 1416 |
|
|
2019
Q2 | $25M | Sell |
551,000
-1,781,600
| -76% | -$83M | 0.01% | 1675 |
|
|
2019
Q1 | $111M | Buy |
2,332,600
+1,742,200
| +295% | +$86.8M | 0.03% | 595 |
|
|
2018
Q4 | $30.7M | Buy |
590,400
+151,100
| +34% | +$8.12M | 0.01% | 1469 |
|
|
2018
Q3 | $27.3M | Sell |
439,300
-209,200
| -32% | -$12.4M | 0.01% | 1692 |
|
|
2018
Q2 | $35.9M | Sell |
648,500
-188,400
| -23% | -$10.2M | 0.01% | 1468 |
|
|
2018
Q1 | $52.9M | Buy |
836,900
+176,300
| +27% | +$11.3M | 0.01% | 1154 |
|
|
2017
Q4 | $40.5M | Buy |
660,600
+115,100
| +21% | +$7.2M | 0.01% | 1441 |
|
|
2017
Q3 | $34.8M | Sell |
545,500
-271,600
| -33% | -$15.9M | 0.01% | 1543 |
|
|
2017
Q2 | $45.5M | Sell |
817,100
-2,868,200
| -78% | -$156M | 0.01% | 1305 |
|
|
2017
Q1 | $200M | Buy |
3,685,300
+2,166,000
| +143% | +$119M | 0.05% | 387 |
|
|
2016
Q4 | $88.8M | Buy |
1,519,300
+136,300
| +10% | +$7.45M | 0.03% | 853 |
|
|
2016
Q3 | $74.6M | Buy |
1,383,000
+5,000
| +0.4% | +$321K | 0.02% | 908 |
|
|
2016
Q2 | $101M | Sell |
1,378,000
-331,700
| -19% | -$23.4M | 0.03% | 668 |
|
|
2016
Q1 | $109M | Buy |
1,709,700
+1,191,500
| +230% | +$75.1M | 0.04% | 618 |
|
|
2015
Q4 | $35.6M | Sell |
518,200
-1,107,800
| -68% | -$73.2M | 0.01% | 1359 |
|
|
2015
Q3 | $96.3M | Buy |
1,626,000
+463,300
| +40% | +$29.4M | 0.03% | 643 |
|
|
2015
Q2 | $77.4M | Buy |
1,162,700
+683,400
| +143% | +$45M | 0.02% | 820 |
|
|
2015
Q1 | $30.9M | Sell |
479,300
-278,100
| -37% | -$17.4M | 0.01% | 1447 |
|
|
2014
Q4 | $44.7M | Buy |
757,400
+56,000
| +8% | +$3.16M | 0.01% | 1200 |
|
|
2014
Q3 | $35.9M | Sell |
701,400
-491,000
| -41% | -$24.5M | 0.01% | 1328 |
|
|
2014
Q2 | $57.8M | Buy |
1,192,400
+105,500
| +10% | +$5.2M | 0.02% | 985 |
|
|
2014
Q1 | $56.5M | Sell |
1,086,900
-748,300
| -41% | -$39.8M | 0.02% | 975 |
|
|
2013
Q4 | $97.5M | Buy |
1,835,200
+735,400
| +67% | +$37.5M | 0.03% | 643 |
|
|
2013
Q3 | $50.9M | Sell |
1,099,800
-78,000
| -7% | -$3.42M | 0.02% | 943 |
|
|
2013
Q2 | $52.6M | Buy |
+1,177,800
| New | +$51.1M | 0.02% | 874 |
|
Other funds holding BMY
VCM
VPM
Goldman Sachs's BMY Position: Q1 2026 in Review
Goldman Sachs reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $250M and leaving 14,054,518 shares worth $852M. The position accounts for 0.1% of the portfolio, ranked #196.
Goldman Sachs first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q1 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Goldman Sachs held 14,054,518 shares of Bristol-Myers Squibb worth $852M as of Q1 2026.
- Goldman Sachs sold 4,288,459 Bristol-Myers Squibb shares in Q1 2026, an estimated $250M.
- Bristol-Myers Squibb made up 0.1% of Goldman Sachs's portfolio in Q1 2026, its #196 holding.
- Goldman Sachs first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Bristol-Myers Squibb position peaked at $1.19B in Q1 2023.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.